1. Home
  2. STAA vs UPBD Comparison

STAA vs UPBD Comparison

Compare STAA & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • UPBD
  • Stock Information
  • Founded
  • STAA 1982
  • UPBD 1986
  • Country
  • STAA United States
  • UPBD United States
  • Employees
  • STAA N/A
  • UPBD N/A
  • Industry
  • STAA Ophthalmic Goods
  • UPBD Diversified Commercial Services
  • Sector
  • STAA Health Care
  • UPBD Consumer Discretionary
  • Exchange
  • STAA Nasdaq
  • UPBD Nasdaq
  • Market Cap
  • STAA 1.4B
  • UPBD 1.5B
  • IPO Year
  • STAA N/A
  • UPBD 1995
  • Fundamental
  • Price
  • STAA $27.88
  • UPBD $25.02
  • Analyst Decision
  • STAA Hold
  • UPBD Buy
  • Analyst Count
  • STAA 8
  • UPBD 4
  • Target Price
  • STAA $22.50
  • UPBD $34.50
  • AVG Volume (30 Days)
  • STAA 720.4K
  • UPBD 612.1K
  • Earning Date
  • STAA 10-29-2025
  • UPBD 10-30-2025
  • Dividend Yield
  • STAA N/A
  • UPBD 6.11%
  • EPS Growth
  • STAA N/A
  • UPBD 78.87
  • EPS
  • STAA N/A
  • UPBD 1.79
  • Revenue
  • STAA $224,449,000.00
  • UPBD $4,481,986,000.00
  • Revenue This Year
  • STAA N/A
  • UPBD $9.99
  • Revenue Next Year
  • STAA $27.59
  • UPBD $8.44
  • P/E Ratio
  • STAA N/A
  • UPBD $14.26
  • Revenue Growth
  • STAA N/A
  • UPBD 7.49
  • 52 Week Low
  • STAA $13.50
  • UPBD $19.65
  • 52 Week High
  • STAA $38.60
  • UPBD $36.00
  • Technical
  • Relative Strength Index (RSI)
  • STAA 68.21
  • UPBD 53.62
  • Support Level
  • STAA $27.52
  • UPBD $24.39
  • Resistance Level
  • STAA $28.38
  • UPBD $25.59
  • Average True Range (ATR)
  • STAA 0.45
  • UPBD 0.64
  • MACD
  • STAA -0.30
  • UPBD -0.01
  • Stochastic Oscillator
  • STAA 63.14
  • UPBD 38.67

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: